Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$223,556
-$18,575 QoQ
Shares Held
23,961
-0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#269
of 639 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026INGALLS & SNYDER LLC holds $6,651,141 across 3 Drug Manufacturers - Specialty & Generic names. HLN ranks #3 (3.4% of the industry book) .
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $223,556 | 23,961 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $242,131 | 24,189 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $247,583 | 24,489 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $245,679 | 27,389 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $296,364 | 28,579 | Shares | Other | 2025-07-31 | |
| 2025-03-31 | $296,300 | 28,795 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $292,544 | 30,665 | Shares | Other | 2025-01-29 | |
| 2024-09-30 | $335,015 | 31,665 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $261,883 | 31,705 | Shares | Other | 2024-07-31 | |
| 2024-03-31 | $273,420 | 32,205 | Shares | Other | 2024-05-13 | |
| 2023-12-31 | $301,506 | 36,635 | Shares | Other | 2024-01-29 | |
| 2023-09-30 | $365,770 | 43,910 | Shares | Other | 2023-11-02 | |
| 2023-06-30 | $367,756 | 43,885 | Shares | Other | 2023-07-27 | |
| 2023-03-31 | $339,519 | 41,710 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $361,520 | 45,190 | Shares | Other | 2023-01-31 | |
| 2022-09-30 | $331,722 | 54,470 | Shares | Other | 2022-10-21 | |
| No filing history on record for this holder in this stock. | ||||||